Should acute bronchitis in the healthy adult or chronic bronchitis in a non respiratory deficient patient be treated by antibiotherapy? Which molecule should be used? In what type of patient?;Faut-il traiter par antibiotiques les bronchites aiguës de l'adulte sain ou du bronchitique chronique non insuffisant respiratoire? Par quelles moléules? Chez quels types de patients?

Medecine et Maladies Infectieuses

Volumn 31, Issue 5, 2001, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTIAM HEXETIL; CEFPODOXIME PROXETIL; CEFUROXIME AXETIL; CIPROFLOXACIN; DOXYCYCLINE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BRONCHITIS; CHRONIC BRONCHITIS; CONFERENCE PAPER; COUGHING; DISEASE EXACERBATION; PATHOPHYSIOLOGY; PATIENT EDUCATION; RESPIRATORY FAILURE;

EID: 33845720672     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(01)00200-1     Document Type: Conference Paper

References (62)

1. Acute bronchitis: Results of U.S. and european trials of antibiotic therapy
2. Pulmonary function in uncomplicated influenza
3. Changes in pulmonary function after naturally acquired respiratory infection in normal persons
4. Evidence that Chlamydia pneumoniae causes pneumoniae and bronchitis
5. Chlamydia pneumoniae pneumonia in hospitalized patients
6. Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice
7. Randomized controlled trial of antibiotics in patients with cough and purulent sputum
8. Les infections respiratoires. 4ème conférence de consensus en thérapeutique anti-infectieuse de la Société de Pathologie Infectieuse de Langue Française
9. Infections respiratoires basses de l'adulte: Pneumonie communautaire et bronchite aiguë
10. A virologic study of chronic bronchitis
11. Bacterial flora of the respiratory tract in chronic bronchitis: Comparison of transtracheal, fiberbronchoscopic and oropharyngeal sampling methods
12. Bacteriology of the lower respiratory tract as determined by fiberoptic bronchoscopic and transtracheal aspiration
13. Bacteriologic flora of the lower respiratory tract
14. A comparison of transtracheal aspiration with older methods of determining the bacterial flora of the lower respiratory tract
15. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function
16. Infective factors in exacerbation of bronchitis and asthma
17. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung diseases
18. Mycoplasma infections in patients with chronic obstructive pulmonary disease
19. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
20. Exacerbations of chronic bronchitis. Treatment with oxytetracycline
21. Prophylactic use of oxytetracyclin for exacerbations of chronic bronchitis
22. Value of ampicillin, in the hospital treatment of exacerbations of chronic bronchitis
23. Antibiotic therapy of acute exacerbations of chronic bronchitis
24. A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function test
25. Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis
26. Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis
27. Efficacy of oral Ciprofloxacin vs Clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis
28. Randomized, double blind study of ciprofloxacin and Cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis
29. Etiology, susceptibility and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID versus Clarithromycin 500 mg BID
30. A 1 year community based health economic study of Ciprofloxacin versus usual antibiotic treatment in acute exacerbations of chronic bronchitis
31. Efficacy and safety of 10 day course of 400 or 600 mg of Grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: Comparison with a 10 day course of 500 mg of Ciprofloxacin twice daily
32. Lower respiratory tract infection therapy: The role of Ciprofloxacin
33. Levofloxacin versus Cefuroxime Axetil in the treatment of acute exacerbation of chronic bronchitis: Results of a randomized, double blind study
34. Trovafloxacin versus Amoxicilline/Clavulanic acid in the treatment of acute exacerbations of chronic bronchitis
35. Randomized, double blind study of Grepafloxacin versus Amoxicillin in patients with acute bacterial exacerbations of chronic bronchitis
36. Treatment of acute exacerbations of chronic bronchitis: Comparison of Trovafloxacin and Amoxicillin in a multicentre, double blind double dummy study
37. Comparative safety and efficacy of Sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double blind, randomized, parallel, multicentre study
38. Sparfloxacin versus Ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis
39. Safety and efficacy of oral Levofloxacin versus Cefuroxime Axetil in acute bacterial exacerbations of chronic bronchitis
40. Multicenter randomized study comparing efficacy and safety of oral Levofloxacin and Cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis
41. Comparative safety and efficacy of Clarithromycin and Ampicillin in the treatment of out patients with acute bacterial exacerbation of chronic bronchitis
42. Clarithromycin versus Cefaclor for the treatment of mild to moderate acute bacterial bronchitis
43. Comparaison de l'efficacité et de la tolérance de la Clarithromycine et du Cefpodoxime proxetil dans le traitement des surinfections aiguës des bronchopneumopathes chroniques obstructifs
44. Double blind, randomized study comparing the efficacies and safeties of a short (3-day) course of Azithromycin and a 5 day course of Amoxicillin in patients with acute exacerbations of chronic bronchitis
45. Efficacy and tolerability of Azithromycin versus Roxithromycin in the treatment of acute lower respiratory tract infections
46. A short (3 day) course of Azithromycin tablets versus a 10 day course of Amoxicillin - Clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long term outcome
47. Efficacy and tolerability of Azithromycin versus Amoxicillin - Clavulanic and in acute purulent exacerbation of chronic bronchitis
48. A multicentre study comparing safety and efficacy of Dirithromycin with Erythromycin in the treatment of bronchitis
49. Clinical efficacy of dirithromycine in acute exacerbations of chronic bronchitis
50. Dirithromycin versus Amoxiclav in the treatment of acute exacerbations of chronic bronchitis
51. Five day Dirithromycin therapy is as effective as seven day Erythromycin therapy for acute exacerbations of chronic bronchitis
52. A comparison of 5 days of Dirithromycin and 7 days of Clarithromycin in acute bacterial exacerbation of chronic bronchitis
53. A comparison of 5 days of Dirithromycin and 7 days of Roxithromycin in acute bacterial exacerbation of chronic bronchitis
54. Comparison of the efficacy and safety of a short course of Ceftibuten with that of Amoxicilline/Clavulanate in the treatment of acute exacerbation of chronic bronchitis
55. Comparison of Ceftibuten versus Amoxicillin/Clavulanate in the treatment of acute exacerbations of chronic bronchitis
56. A comparison of Cefpodoxime proxetil and Cefaclor in the treatment of acute exacerbation of COPD in adults
57. Comparison of Ceftibuten once daily and Amoxicillin/Clavulanate 3 times daily in the acute exacerbations of chronic bronchitis
58. Randomized comparison of once daily Ceftibuten and twice daily Clarithromycin in the treatment of acute exacerbation of chronic bronchitis
59. Traitement des exacerbations de bronchites chroniques: Cefuroxime IM avec relais per os par Cefuroxime Axetil versus Ceftriaxone
60. Successful treatment of respiratory tract infections in patients with chronic respiratory disease. How to make objective conclusions?
61. Clinical studies in chronic bronchitis: A need for better definition and classification of severity
62. Acute exacerbations of chronic bronchitis: An international comparison